Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-14

Clinical Trial Update: Psilocybin in Chronic Low Back Pain and Depression [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial at Johns Hopkins is evaluating the safety and potential effects of psilocybin for chronic low back pain and depression, currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psilocybin (psilocybin)

Snippet

Sponsor: Johns Hopkins University | Conditions: Chronic Low-back Pain, Depression | Phase 1 | Status: RECRUITING